Pseudocholinesterase activity in thyroid disease
Open Access
- 1 November 1965
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 18 (6), 811-812
- https://doi.org/10.1136/jcp.18.6.811
Abstract
The present evidence indicates that serum pseudocholinesterase activity is increased to about 20% above the normal level in thyrotoxicosis and decreased by about 30% in myxoedema. Treatment restores the esterase level to the average mean activity of random normal as the patient becomes euthyroid. There is no evidence in the present investigation that any of the pseudocholinesterase variants modify these conclusions.This publication has 15 references indexed in Scilit:
- The Pseudocholinesterase Variants: Esterase Levels and Increased Resistance to FluorideHuman Heredity, 1964
- Genetical studies on a new variant of serum cholinesterase detected by electrophoresisAnnals of Human Genetics, 1963
- Differential Inhibition of Human Serum Cholinesterase with Fluoride: Recognition of Two New PhenotypesNature, 1961
- ON DISTRIBUTION AND INHERITANCE OF ATYPICAL FORMS OF HUMAN SERUM CHOLINESTERASE, AS INDICATED BY DIBUCAINE NUMBERSCanadian Journal of Biochemistry and Physiology, 1957
- A Relationship between Body Fat and Plasma Pseudo-CholinesteraseBritish Journal of Nutrition, 1954
- [Investigation on activity of serum cholinesterase and on therapeutic effect of intravenous novocain in psoriasis].1954
- Observations on Erythrocyte and Plasma Cholinesterase Activity in Dyscrasias of the BloodBlood, 1951
- Blood Cholinesterase Levels in Workers Exposed to Organo-phosphorus InsecticidesBMJ, 1951
- Blood Cholinesterase Levels and Range of Personal Variation in a Healthy Adult PopulationBMJ, 1951
- LIVER CHOLINE-ESTERASE IN MALNOURISHED INFANTSThe Lancet, 1950